SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-000984
Filing Date
2021-01-05
Accepted
2021-01-05 16:49:12
Documents
13
Period of Report
2021-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm211725d1_8k.htm   iXBRL 8-K 28534
2 EXHIBIT 2.1 tm211725d1_ex2-1.htm EX-2.1 176348
  Complete submission text file 0001104659-21-000984.txt   418926

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rytm-20210105.xsd EX-101.SCH 3187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20210105_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20210105_pre.xml EX-101.PRE 22711
6 EXTRACTED XBRL INSTANCE DOCUMENT tm211725d1_8k_htm.xml XML 3723
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 21506572
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences